Probiotics Ingredients

B. bifidum-BGN4^® and B. longum-BORI^® are discovered by Dr. Geun-Eog Ji, a professor at Seoul National University and a world leading specialist in the research of probiotics. Patented BGN4^® has anti-allergy, anti-tumor, anti-infection and bowel regulation effects with strong scientific evidence. Patented BORI^® has a unique property on inhibiting rotavirus as well as other intestinal infections.

BIFIDO fully utilizes science in nutritious and functional food materials for the improvement of human health and well-being. Focusing on basic research and product development using probiotics, nowadays BIFIDO's Bifidobacterium and other lactic acid bacteria are being applied widely in functional foods. Especially, we are in the leading edge in the development of human - health promoting Bifidobacterium.

SNZ^® 1969 is a unique Lactobacillus sporogenes/Bacillus coagulans strain, more correctly called Bacillus coagulans, GRAS notified lactic-acid producing bacteria that are generally recognized as a probiotic. SNZ^® does exhibit traits that are advantageous over other Lactobacilli, including the commonly used Lactobacillus acidophilus. It can tolerate higher temperatures, which makes manufacturing easier and cheaper. It also prolongs the shelf life of the supplements. L. sporogenes also tolerate the acidity of the gastric system.

Clostridium butyricum is a butyric acid bacterium that can produce endospores, which is a key characteristic related to its ability to survive at lower pH and relatively higher bile concentrations. It promotes the growth of Lactobacillus and Bifidobacterium and inhibits antibiotic-associated diarrhea. Oral administration of C. butyricum M588 strain may enhance immunity in the respiratory system.

The only yeast that can be recognized as probiotics, SB-55^® is a unique Saccharomyces cerevisiae. There are numerous studies showing the efficacy of S. cerevisiae SB-55^® in the treatment and prevention of gastrointestinal disorders including acute diarrhea, irritable bowel syndrome (IBS), recurrent Clostridium difficile infection, inflammatory bowel disease, antibiotic-associated diarrhea and so on.

HU58™ is a bacterial spore of the Bacillus subtilis strain isolated from the human intestinal tract of healthy volunteers. The product has been well studied and is manufactured under license from Royal Holloway College of the University of London (RHUL). Indications for use include gut health, antibiotic-induced diarrhea, ulcerative colitis, bacterial vaginosis, urinary tract infection (UTI), and candida vaginal infections. Moreover, HU58™ has been shown in studies to have superior sporulation and germination efficiency. It is stable at extreme pH levels and high temperatures, as well as challenging storage / manufacturing conditions.